395 posters, 1 audios, 13 topics, 29 sessions, 1,056 authors, 461 institutions

51st Annual Regional Anesthesiology and Acute Pain Medicine Meeting

April 16 - 18, 2026 | Phoenix, Arizona

Authors

Showing 3 results for author "Jeffrey P. Smith".

Back to authors

Thumbnail for Efficacy and safety of MR-107A-02 (novel meloxicam formulation) for treatment of acute moderate-to-severe pain after herniorrhaphy

2317724

Efficacy and safety of MR-107A-02 (novel meloxicam formulation) for treatment of acute moderate-to-severe pain after herniorrhaphy

Fernando Cabrera, Todd M. Bertoch, Jessica C. McCoun, Harold S. Minkowitz, Susanne Vogt, Scott Haughie, Kathleen Ocasio, Jeffrey P. Smith

Viatris, Viatris, Morgantown, WV, USA, CenExel JBR, Salt Lake City, UT, USA, Viatris/Mylan Pharma UK Ltd, Viatris Inc., Canonsburg, PA, USA, Evolution Research Group, Bellaire, Texas, USA, Viatris, Bad Homburg,...

Poster Presenter: Fernando Cabrera

2317792

Opioid sparing effect of MR-107A-02 for the treatment of acute moderate-to-severe pain following bunionectomy and herniorrhaphy

Fernando Cabrera, Todd M. Bertoch, Ira Gottlieb, Harold S. Minkowitz, Susanne Vogt, Scott Haughie, Kathleen Ocasio, Jeffrey P. Smith

Viatris, Viatris, Morgantown, WV, USA, CenExel JBR, Salt Lake City, UT, USA, Chesapeake Research Group, Pasadena, Maryland, Viatris/Mylan Pharma UK Ltd, Viatris Inc., Canonsburg, PA, USA, Evolution Research Gro...

Authors

Efficacy and safety of MR-107A-02 (novel meloxicam formulation) for treatment of acute moderate-to-severe pain after herniorrhaphy

Opioid sparing effect of MR-107A-02 for the treatment of acute moderate-to-severe pain following bunionectomy and herniorrhaphy

Efficacy and safety of MR-107A-02 (novel meloxicam formulation) for treatment of acute moderate-to-severe pain after bunionectomy